HOXA7 Impairs Osteogenic Differentiation via p38/JNK Signaling: Implications for Osteoporosis

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Osteoporosis (OP) is a skeletal disorder characterized by decreased bone mass and increased fracture risk.
• Understanding the molecular mechanisms underlying osteoblast differentiation and function is crucial for developing effective OP treatments.

Purpose of the Study:

• To investigate the role and mechanism of Homeobox A7 (HOXA7) in osteoporosis.
• To explore HOXA7's impact on osteogenic differentiation, cell proliferation, apoptosis, and autophagy.
• To elucidate the involvement of the p38 MAPK/JNK pathway in HOXA7-mediated effects.

Main Methods:

• Assessed HOXA7 gene and protein expression in human bone marrow-derived mesenchymal stem cells (hBMSCs) and MC3T3-E1 cells.
• Evaluated the effect of HOXA7 on osteogenic differentiation, proliferation, apoptosis, and autophagy.
• Investigated the p38 MAPK/JNK signaling pathway and the impact of pathway inhibitors (SP600125, SB203580).

Main Results:

• HOXA7 overexpression inhibited osteogenic differentiation and key markers (OPG, OPN, RUNX2) in hBMSCs.
• HOXA7 decreased proliferation and promoted apoptosis in MC3T3-E1 cells, while also modulating autophagy.
• HOXA7 suppressed the activation of p38 MAPK and JNK pathways in MC3T3-E1 cells, and pathway inhibitors reversed HOXA7 silencing effects.

Conclusions:

• HOXA7 negatively regulates osteogenesis and osteoblast proliferation while promoting apoptosis.
• The p38 MAPK/JNK signaling pathway is a key mediator of HOXA7's effects on osteoblasts.
• HOXA7 represents a potential therapeutic target for osteoporosis treatment.